Integrating electrodermal biofeedback into pharmacologic treatment of grand mal XXXX .

@entity1 @entity410 @entity148 @entity3173
Electrodermal activity (EDA) and electrodermal biofeedback, when integrated with pharmacologic treatments, indicate promising methods for the treatment of grand mal @entity410 . They can be used to monitor @entity1 arousal and help @entity1 learn new strategies to better cope with stress and @entity148 . Our proposed method can possibly reduce the number of crises for @entity1 who are dependent on pharmacologic therapy and can improve their quality of life. This article describes the scientific background of electrodermal monitoring and electrodermal biofeedback for @entity1 affected by grand mal @entity410 . In this study, we have reported a clinical case study. The @entity1 was treated for 2 years with electrodermal biofeedback to augment pharmacologic treatments. The trial has been designed in accordance with "n = 1 case study research". Our results have shown that our methods could achieve a significant @entity3173 and sympathetic arousal when applied. The @entity1 under consideration was also relaxed and exhibited greater competency to cope with stress. Additionally, the @entity1 's sense of mastery and self-efficacy was enhanced.
